- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Harnessing synthetic lethality to predict the response to cancer treatment ; volume:9 ; number:1 ; day:29 ; month:6 ; year:2018 ; pages:1-12 ; date:12.2018
Nature Communications ; 9, Heft 1 (29.6.2018), 1-12, 12.2018
- Creator
-
Lee, Joo Sang
- Contributor
-
Das, Avinash
Jerby-Arnon, Livnat
Arafeh, Rand
Auslander, Noam
Davidson, Matthew
McGarry, Lynn
James, Daniel
Amzallag, Arnaud
Park, Seung Gu
Cheng, Kuoyuan
Robinson, Welles
Atias, Dikla
Stossel, Chani
Buzhor, Ella
Stein, Gidi
Waterfall, Joshua J.
Meltzer, Paul S.
Golan, Talia
Hannenhalli, Sridhar
Gottlieb, Eyal
Benes, Cyril H.
Samuels, Yardena
Shanks, Emma
Ruppin, Eytan
SpringerLink (Online service)
- DOI
-
10.1038/s41467-018-04647-1
- URN
-
urn:nbn:de:101:1-2018090114502104115201
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lee, Joo Sang
- Das, Avinash
- Jerby-Arnon, Livnat
- Arafeh, Rand
- Auslander, Noam
- Davidson, Matthew
- McGarry, Lynn
- James, Daniel
- Amzallag, Arnaud
- Park, Seung Gu
- Cheng, Kuoyuan
- Robinson, Welles
- Atias, Dikla
- Stossel, Chani
- Buzhor, Ella
- Stein, Gidi
- Waterfall, Joshua J.
- Meltzer, Paul S.
- Golan, Talia
- Hannenhalli, Sridhar
- Gottlieb, Eyal
- Benes, Cyril H.
- Samuels, Yardena
- Shanks, Emma
- Ruppin, Eytan
- SpringerLink (Online service)
Other Objects (12)
Modeling synthetic lethality
An in-silico approach to predict and exploit synthetic lethality in cancer metabolism
Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response
Wnt signaling inhibition confers induced synthetic lethality to PARP inhibitors
Synthetic lethality in lung cancer and translation to clinical therapies
Epigenetic synthetic lethality approaches in cancer therapy
Two mitochondrial DNA polymorphisms modulate cardiolipin binding and lead to synthetic lethality
Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy
Advances in synthetic lethality modalities for glioblastoma multiforme
Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells
Telomere dysfunction and synthetic lethality in chronic lymphocytic leukemia
Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality
Modeling synthetic lethality
An in-silico approach to predict and exploit synthetic lethality in cancer metabolism
Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response
Wnt signaling inhibition confers induced synthetic lethality to PARP inhibitors
Synthetic lethality in lung cancer and translation to clinical therapies
Epigenetic synthetic lethality approaches in cancer therapy
Two mitochondrial DNA polymorphisms modulate cardiolipin binding and lead to synthetic lethality
Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy
Advances in synthetic lethality modalities for glioblastoma multiforme
Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells
Telomere dysfunction and synthetic lethality in chronic lymphocytic leukemia
Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality
Modeling synthetic lethality
An in-silico approach to predict and exploit synthetic lethality in cancer metabolism
Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response
Wnt signaling inhibition confers induced synthetic lethality to PARP inhibitors
Synthetic lethality in lung cancer and translation to clinical therapies
Epigenetic synthetic lethality approaches in cancer therapy
Two mitochondrial DNA polymorphisms modulate cardiolipin binding and lead to synthetic lethality
Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy
Advances in synthetic lethality modalities for glioblastoma multiforme
Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells
Telomere dysfunction and synthetic lethality in chronic lymphocytic leukemia